Unicycive Therapeutics, Inc. Share Price
NASDAQ: UNCY | Micro CapUnicycive Therapeutics, Inc. Stock Performance
Unicycive Therapeutics, Inc. Share Price Today
As of 30 October 2026, Unicycive Therapeutics, Inc.'s share price is $3.81. The stock opened at $3.79, compared to its previous close of $3.75. During today's trading session, Unicycive Therapeutics, Inc.'s share price traded between $3.74 and $3.86, with an average price of $3.80. Over the past 52 weeks, the stock has recorded a high of $8.74 and a low of $3.35. In terms of performance, Unicycive Therapeutics, Inc.'s share price has declined by 50.20% over the last six months and is down 19.51% on a year-on-year basis.
Unicycive Therapeutics, Inc. Share Price Chart
Unicycive Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Unicycive Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Unicycive Therapeutics, Inc.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Unicycive Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.71 | $3.82 | -18.72% |
Sep 2026 | $5.17 | $4.70 | -14.39% |
Aug 2026 | $5.00 | $5.49 | +9.47% |
Jul 2026 | $4.58 | $5.01 | +6.03% |
Jun 2026 | $7.50 | $4.73 | -35.73% |
May 2026 | $7.72 | $7.36 | -3.92% |
Apr 2026 | $6.78 | $7.66 | +16.50% |
Mar 2026 | $6.70 | $6.58 | -5.26% |
Feb 2026 | $6.00 | $6.94 | +16.54% |
Jan 2026 | $5.79 | $5.96 | +3.21% |
Dec 2025 | $6.42 | $5.77 | -10.68% |
Nov 2025 | $4.74 | $6.46 | +36.29% |